Reuters
Health and science correspondent for Reuters; former Science Editor at Newsweek magazine
PROFILE
Sharon Begley
Guest
FROM Sharon Begley
To the Point
Biosecurity Breaches at the CDC Federal health officials have disclosed breaches of safety at the Centers for Disease Control and Prevention’s own laboratories. The latest safety breach involves avian flu which could be even more serious than the anthrax shipped from one lab to another, or the vials of smallpox found in an unused storage room. Even Director Dr. Thomas Frieden says it may be time to reduce the number of labs working with some of the planet’s most dangerous microbes. Sharon Begley is reporting the story for the Reuters News Service.
Press Play with Madeleine Brand
Making (Designer?) Babies with Three Parents Medical advisers to the US Food & Drug Administration held hearings this week on whether to approve a controversial procedure called "three-parent in vitro fertilization.” The procedure is meant to help women with a genetic defect to have healthy babies. But it has also raised objections from people who see this as a slippery slope to “designer babies.”
To the Point
Would Less Testing Make for Better Medical Care? When it comes to cancer, the watchword has long been "early detection," routine testing for common forms of the disease. But the United States Preventative Services Task Force says testing for common cancers may do more harm than good , to men as well as to women. First it was mammograms for breast cancer ; now it's the PSA test for cancer of the prostate gland . In both cases, there's been a powerful blacklash. We focus on the prostate findings, which some specialists say they plan to ignore. Are they afraid of lawsuits? Will patients demand early detection? Will insurance companies deny reimbursement? Will the findings cut the cost of health care by establishing a form of rationing?
To the Point
Breast Cancer Study Raises More Questions on Mammograms Last year an influential federal task force said routine annual mammograms were not necessary for women in their 40's. That led to concerns about insurance companies rationing medical services. Now a new study of 40,000 women diagnosed with breast cancer in Norway between 1986 and 2005 says treatment has advanced so much that mammograms may, indeed, not be so important. Sharon Begley is science editor of Newsweek magazine.
Which Way, L.A.?
Cancer and the Business of Medicine The annual meeting of the American Society of Clinical Oncology brings together the latest on cancer research and treatment. Patients and their families pray for news of a breakthrough. Businesses look for investments; entrepreneurs look for opportunities. Last week in Chicago, some 4000 studies were presented to 30,000 top experts — but one warned there's "a growing sense that our optimism needs to be tempered a bit." We hear from him and others about how financial conflicts, personal habits and occupational hazards impact inroads against the disease.
To the Point
Cancer: Big Business and the Painstaking Search for a Cure Five years ago, cancer researchers were predicting "miracle treatments" — even vaccines -- based on the billions being spent on genetics. But the more they know, the more complicated cancer becomes, and even the American Cancer Society has tempered its optimism. Cancer victims, and members of Congress, are increasingly impatient with the slow pace of improvement. Are financial conflicts part of the problem? Given what’s known about personal habits like smoking, about occupational hazards and the environment, should more be spent on prevention?
To the Point
Green Products as Modern Indulgences "On the 40th Anniversary of Earth Day, Let's…Go shopping!" reads a headline from Newsweek magazine which argues that "buying green and changing personal behavior won't save the planet." The Gallup Poll has found that 76% of Americans have bought products specifically because they thought they were better for the environment. Sharon Begley, science editor for Newsweek , calls that evidence that "green activism has gone seriously off course."
Recommended
To the Point
Is the threat from Russia missing from the Russia meddling probe? There's much being made about the Trump administration's possible ties with Russia. But the bottom line is Russia's effort to influence American democracy. Do the President and his aides care enough to take action before voters go back to the polls?
To the Point
What is Trump's plan for Middle East peace? On his first foreign tour, President Trump has promised "peace" between Israel and the Palestinians. Are there any details for re-starting talks that have been stalled for the past three years?
To the Point
Trump's new look at civil rights and global warming President Trump is reportedly ready to pull the US out of the Paris Agreement on Climate Change. We look at the possible consequences. On the second half of the program, we hear about cuts in Obama-Era civil rights programs called for by the Trump Administration's first budget plan.
To the Point
Ex-FBI Director Comey tells his side of the story Today, former FBI Director James Comey came close to calling the President who fired him a liar. The White House denied the claim and called it insulting, but Republican Senators did not challenge Comey’s truthfulness. Many questions remain: did the President try to obstruct a federal investigation? Later, we’ll go behind the “velvet rope” for a look at 5-Star health care for the richest Americans.